Evaluating the Impact of Data Exclusivity on the Price of Pharmaceutical Imports
[Mike Palmedo] I have a new paper in the Journal of Globalization and Development. "Evaluating the Impact of Data Exclusivity on the Price of Pharmaceutical Imports" finds large increases in the price of imported medicines when the U.S.'s trading partners implement data exclusivity to meet FTA obligations. The full impact of data exclusivity laws took many years to become apparent though observation of aggregated prices, because the laws themselves only applied to medicines new medicines.
